일봉 히스토리컬 데이터와 계정별 기본 설정
공시·실적·리서치·기관 변화를 시간 역순으로 정리
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
컨센서스 vs 실제, 그리고 매출 추이
투자의견·목표주가 변경
CytoMed Therapeutics(GDTC) Stock Options Chain | Quotes & News - Moomoo
CytoMed Therapeutics(GDTC) Stock Options Chain | Quotes & News Moomoo
CytoMed Therapeutics (GDTC) Slips 4%: Testing Key Support at $0.91 Amid Light Volume - ETH Profile - dars.gov.et
CytoMed Therapeutics (GDTC) Slips 4%: Testing Key Support at $0.91 Amid Light Volume - ETH Profile dars.gov.et
Price to sales forward of CytoMed Therapeutics Limited – FWB:F98 - TradingView
Price to sales forward of CytoMed Therapeutics Limited – FWB:F98 TradingView
CytoMed Therapeutics (GDTC) Climbs 5.1% as Shares Approach Resistance at $1.08 - Max Pain Level - dars.gov.et
CytoMed Therapeutics (GDTC) Climbs 5.1% as Shares Approach Resistance at $1.08 - Max Pain Level dars.gov.et
CytoMed Therapeutics (GDTC) Stock Forecast & Analyst Ratings - Moomoo
CytoMed Therapeutics (GDTC) Stock Forecast & Analyst Ratings Moomoo
Enterprise value to revenue forward of CytoMed Therapeutics Limited – NASDAQ:GDTC - TradingView
Enterprise value to revenue forward of CytoMed Therapeutics Limited – NASDAQ:GDTC TradingView
표시할 실적 데이터가 없습니다.
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2024. 10. 10. | Benchmark | — | 의견 유지 | Speculative Buy → Speculative Buy | — | Benchmark: Speculative Buy |
| 2024. 06. 11. | Benchmark | — | 의견 유지 | Speculative Buy → Speculative Buy | — | Benchmark: Speculative Buy |
| 2023. 12. 04. | Benchmark | — | 의견 유지 | Speculative Buy → Speculative Buy | — | Benchmark: Speculative Buy |
| 2023. 07. 21. | Benchmark | — | 커버리지 개시 | — → Speculative Buy | — | Benchmark: Speculative Buy |
가격 데이터
표시할 보유 데이터가 없습니다.